Mutation of a putative protein degradation gene LITAF/SIMPLE in Charcot-Marie-Tooth disease 1C

Neurology

Volumn 60, Issue 1, 2003, Pages 22-26

  Street, V A ^a   Bennett, C L ^a   Goldy, J D ^a   Shirk, A J ^a   Kleopa, K A ^a   Tempel, B L ^a   Lipe, H P ^a   Scherer, S S ^a   Bird, T D ^a   Chance, P F ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; LIPOPOLYSACCARIDE INDUCED TUMOR NECROSIS FACTOR ALPHA FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; AUTOSOMAL DOMINANT DISORDER; CASE REPORT; CLUSTER ANALYSIS; DEMYELINATION; FEMALE; GENE; GENE LITAF; GENE MAPPING; GENE MUTATION; HEREDITARY MOTOR SENSORY NEUROPATHY; HEREDITY; HUMAN; HUMAN TISSUE; MALE; MISSENSE MUTATION; MOLECULAR CLONING; NERVE BIOPSY; NERVE TRANSECTION; NORTHERN BLOTTING; PATHOGENESIS; PEDIGREE; PRIORITY JOURNAL; PROTEIN DEGRADATION; WESTERN BLOTTING;

EID: 0037435540     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.60.1.22     Document Type: Article

References (31)

1. Dyck PJ, Lambert EH. Lower motor and primary sensory neuron diseases with peroneal muscular atrophy. II. Neurologic, genetic and electrophysiologic findings in various neuronal degenerations. Arch Neurol 1968;18:619-625.
2. Skre H. Genetic and clinical aspects of Charcet-Charcot-Marie-Tooth's disease. Clin Genet 1974;6:98-118.
3. Lupski JR, Montes de Oca-Luna R, Slaugenhaupt S, et al. DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell 1991;66:219-232.
4. Raeymaekers P, Timmerman V, Nelis E, et al., Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type 1a (CMT 1a). Neuromuscul Disord 1991;1:93-97.
5. Matsunami N, Smith B, Ballard L, et al. Peripheral myelin protein-22 gene maps in the duplication in chromosome 17p11.2 associated with Charcot-Marie-Tooth 1A. Nat Genet 1992;1:176-179.
6. Patel PI, Roa BB, Welcher AA, et al. The gene for the peripheral myelin protein PMP-22 is a candidate for Charcot-Marie-Tooth disease type 1A. Nat Genet 1992;1:159-165.
7. Timmerman V, Nelis E, Van Hul W, Nieuwenhuijsen BW, et al. The peripheral myelin protein gene PMP-22 is contained within the Charcot-Marie-Tooth disease type 1A duplication. Nat Genet 1992;1:171-175.
8. Valentijn LJ, Bolhuis PA, Zorn I, et al. The peripheral myelin gene PMP-22/GAS-3 is duplicated in Charcot-Marie-Tooth disease type 1A. Nat Genet 1992;1:166-170.
9. Warner LE, Roa BB, Lupski JR. Absence of PMP22 coding region mutations in CMT1A duplication patients: further evidence supporting gene dosage as a mechanism for Charcot-Marie-Tooth disease type 1A. Hum Mut 1996;8:362-365.
10. Valentijn LJ, Baas F, Wolterman RA, et al. Identical point mutations of PMP-22 in Trembler-J mouse and Charcot-Marie-Tooth disease type 1A. Nat Genet 1992;2:288-291.
11. Roa BB, Garcia CA, Suter U, et al. Charcot-Marie-Tooth disease type 1A. Association with a spontaneous point mutation in the PMP22 gene. N Engl J Med 1993;329:96-101.
12. Nelis E, Timmerman V, De Jonghe P, Van Broeckhoven C. Identification of a 5′ splice site mutation in the PMP-22 gene in autosomal dominant Charcot-Marie-Tooth disease type 1. Hum Mol Genet 1994;3:515-516.
13. Kamholz J, Menichella D, Jani A, et al. Charcot-Marie-Tooth disease type 1: molecular pathogenesis to gene therapy. Brain 2000;123:222-233.
14. Warner LE, Mancias P, Butler IJ, et al. Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies. Nat Genet 1998;18:382-384.
15. Chance PF, Bird TD, O'Connell P, Lipe H, Lalouel J-M, Leppert M. Genetic linkage and heterogeneity in type 1 Charcot-Marie-Tooth disease (hereditary motor and sensory neuropathy type 1). Am J Hum Genet 1990;47:915-925.
16. Street VA, Goldy JD, Golden AS, Tempel BL, Bird TD, Chance PF. Mapping of Charcot-Marie-Tooth disease type 1C to chromosome 16p identifies a novel locus for demyelinating neuropathies. Am J Hum Genet 2002;70:244-250.
17. Myokai F, Takashiba S, Lebo R, Amar S. A novel lipopolysaccharideinduced transcription factor regulating tumor necrosis factor alpha gene expression: molecular cloning, sequencing, characterization, and chromosomal assignment. Proc Natl Acad Sci USA 1999;96:4518-4523.
18. Moriwaki Y, Begum NA, Kobayashi M, Matsumoto M, Toyoshima K, Seya T. Mycobacterium bovis Bacillus Calmette-Guerin and its cell wall complex induce a novel lysosomal membrane protein, SIMPLE, that bridges the missing link between lipopolysaccharide and p53-inducible gene, LITAF(PIG7), and estrogen-inducible gene, EET-1. J Biol Chem 2001;276:23065-23076.
19. Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B. A model for p53-induced apoptosis. Nature 1997;389:300-305.
20. Sancho S, Young P, Suter U. Regulation of Schwann cell proliferation and apoptosis in PMP22-deficient mice and mouse models of Charcot-Marie-Tooth disease type 1A. Brain 2001;124:2177-2187.
21. Neitzel H. A routine method for the establishment of permanent growing lymphoblastoid cell lines. Hum Genet 1986;73:320-326.
22. Scarlato M, Xu T, Bannerman P, et al. Axon-Schwann cell interactions regulate the expression of fibroblast growth factor-5 (FGF-5). J Neurosci Res 2001;66:16-22.
23. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979;18:5294-5299.
24. Scherer SS, Deschenes SM, Xu YT, Grinspan JB, Fischbeck KH, Paul DL. Connexin32 is a myelin-related protein in the PNS and CNS. J Neurosci 1995;15:8281-8294.
25. Everett LM, Li A, Devaraju G, Caperell-Grant A, Bigsby RM. A novel estrogen-enhanced transcript identified in the rat uterus by differential display. Endocrinology 1997;138:3836-3841.
26. Jolliffe CN, Harvey KF, Haines BP, Parasivam G, Kumar S. Identification of multiple proteins expressed in murine embryos as binding partners for the WW domains of the ubiquitin-protein ligase Nedd4. Biochem J 2000;351:557-565.
27. Snipes GJ, Suter U, Welcher AA, Shooter EM. Characterization of a novel peripheral nervous system myelin protein (PMP-22/SR13). J Cell Biol 1992;117:225-238.
28. Zorick TS, Syroid DE, Arroyo E, Scherer SS, Lemke G. The transcription factors SCIP and Krox-20 mark distinct stages and cell fates in Schwann cell differentiation. Mol Cell Neurosci 1996;8:129-145.
29. Takashiba S, Van Dyke TE, Shapira L, Amar S. Lipopolysaccharideinducible and salicylate-sensitive nuclear factor(s) on human tumor necrosis factor alpha promoter. Infect Immun 1995;63:1529-1534.
30. Pareek S, Notterpek L, Snipes GJ, et al. Neurons promote the translocation of peripheral myelin protein 22 into myelin. J Neurosci 1997;17:7754-7762.
31. Ryan MC, Shooter EM, Notterpek L. Aggresome formation in neuropathy models based on peripheral myelin protein 22 mutations. Neurobiol Dis 2002;10109-118.